Prijeđi na sadržaj

Mosapramin

Izvor: Wikipedija
(Preusmjereno sa stranice Mozapramin)
Mosapramin
(IUPAC) ime
1'-[3-(3-hloro-10,11-dihidro-5H-dibenzo[b,f]azepin-5-il)propil]hexahidro-2H-spiro[imidazo[1,2-a]piridin-3,4'-piperidin]-2-on
Klinički podaci
AHFS/Drugs.com Internacionalno ime leka
Identifikatori
CAS broj 89419-40-9
ATC kod N05AX10
PubChem[1][2] 4257
UNII 04UZQ7O9SJ DaY
KEGG[3] D08235 DaY
Hemijski podaci
Formula C28H35ClN4O 
Mol. masa 479.057 g/mol
SMILES eMolekuli & PubHem
Farmakoinformacioni podaci
Trudnoća ?
Pravni status Prescription only
Način primene Oralno

Mosapramin (Kremin) je atipični antipsihotik koji se koristi u Japanu.[4] On je potentan dopaminski antagonist sa visokim afinitetom za D2, D3, i D4 receptore,[5] i sa umerenim afinitetom za 5-HT2 receptore.[6]

Reference

[uredi | uredi kod]
  1. Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.  edit
  2. Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1. 
  3. Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H. 
  4. Takahashi N, Terao T, Oga T, Okada M. Comparison of risperidone and mosapramine addition to neuroleptic treatment in chronic schizophrenia. Neuropsychobiology. 1999;39(2):81-5. PMID 10072664
  5. Futamura T, Ohashi Y, Yano K, Takahashi Y, Haga K, Fukuda T. The affinities of mosapramine for the dopamine receptor subtypes in human cell lines expressing D2, D3 and D4 receptors. Nippon Yakurigaku Zasshi. (Japanese) 1996 May;107(5):247-53. PMID 8690306
  6. Sumiyoshi T, Suzuki K, Sakamoto H, Yamaguchi N, Mori H, Shiba K, Yokogawa K. Atypicality of several antipsychotics on the basis of in vivo dopamine-D2 and serotonin-5HT2 receptor occupancy. Neuropsychopharmacology. 1995 Feb;12(1):57-64. DOI:10.1016/0893-133X(94)00064-7 PMID 7766287

Povezano

[uredi | uredi kod]

Spoljašnje veze

[uredi | uredi kod]